Found: 9
Select item for more details and to access through your institution.
Rational Use of Danofloxacin for Treatment of Mycoplasma gallisepticum in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 3, p. 403, doi. 10.3390/antibiotics11030403
- By:
- Publication type:
- Article
PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against Streptococcus suis in Piglets.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 2, p. 283, doi. 10.3390/antibiotics11020283
- By:
- Publication type:
- Article
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 7, p. 808, doi. 10.3390/antibiotics10070808
- By:
- Publication type:
- Article
Phage Products for Fighting Antimicrobial Resistance.
- Published in:
- Microorganisms, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/microorganisms10071324
- By:
- Publication type:
- Article
Toxic metabolites, MAPK and Nrf2/Keap1 signaling pathways involved in oxidative toxicity in mice liver after chronic exposure to Mequindox.
- Published in:
- Scientific Reports, 2017, p. 41854, doi. 10.1038/srep41854
- By:
- Publication type:
- Article
Prudent Use of Tylosin for Treatment of Mycoplasma gallisepticum Based on Its Clinical Breakpoint and Lung Microbiota Shift.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.712473
- By:
- Publication type:
- Article
Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.769539
- By:
- Publication type:
- Article
Mechanisms of the Testis Toxicity Induced by Chronic Exposure to Mequindox.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00679
- By:
- Publication type:
- Article
Dosing Regimen of Aditoprim and Sulfamethoxazole Combination for the Glaesserella parasuis Containing Resistance and Virulence Genes.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102058
- By:
- Publication type:
- Article